NAGE
Financials
- Market Capitalization 256.37 M
- Employee 117
- Founded 1999
- CEO N/A
- Website www.niagenbioscience.com
- Headquarter Delaware, United States
- FIGI BBG000BG1J71
- Industry Biotechnology
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 3453 |  MGNX MacroGenics, Inc. - Common Stock | 4.14 USD | +1.47% | +0.98% | +7.81% | +140.70% | 263.72 M USD | ||
| 3454 |  ELDN Eledon Pharmaceuticals, Inc. - Common Stock | 3.20 USD | -3.61% | -7.25% | -6.16% | +24.51% | 260.04 M USD | ||
| 3469 |  YDES YD Bio Limited - Ordinary Shares | 3.54 USD | -8.53% | -24.84% | +66.98% | -55.75% | 250.59 M USD | ||
| 3481 |  CLLS Cellectis S.A. - American Depositary Shares | 3.40 USD | -3.13% | +5.26% | +19.30% | +29.28% | 243.95 M USD |
Frequently asked questions about Niagen Bioscience, Inc. Common Stock
What is the Niagen Bioscience, Inc. Common Stock stock price today?
The current price of Niagen Bioscience, Inc. Common Stock (NAGE) is 3.24. Over the past 24 hours, the stock has changed by +0.93%. Follow the NAGE chart for real-time price dynamics.
What is the stock ticker of Niagen Bioscience, Inc. Common Stock?
Niagen Bioscience, Inc. Common Stock trades under the ticker NAGE. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Niagen Bioscience, Inc. Common Stock stock going up?
NAGE has changed by +0.62% over the last week, -0.92% over the last month, and -34.94% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of Niagen Bioscience, Inc. Common Stock?
Niagen Bioscience, Inc. Common Stock currently has a market capitalization of 256.37 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were Niagen Bioscience, Inc. Common Stock earnings last quarter?
Last quarter, Niagen Bioscience, Inc. Common Stock reported earnings of 0.01 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was Niagen Bioscience, Inc. Common Stock revenue for the last quarter?
Niagen Bioscience, Inc. Common Stock reported quarterly revenue of 29.79 M. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was Niagen Bioscience, Inc. Common Stock net income for the last quarter?
Niagen Bioscience, Inc. Common Stock reported net income of 963 K for the last quarter. The previous quarter showed 6.32 M, which means net income changed by -84.76%.
How many employees does Niagen Bioscience, Inc. Common Stock have?
As of the latest available data, Niagen Bioscience, Inc. Common Stock has 117 employees. Workforce size can provide additional context about the company's scale and operations.
What is Niagen Bioscience, Inc. Common Stock EBITDA?
Niagen Bioscience, Inc. Common Stock EBITDA is 1.17 M, and its EBITDA margin is 3.91%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Niagen Bioscience, Inc. Common Stock stock?
You can buy Niagen Bioscience, Inc. Common Stock (NAGE) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Niagen Bioscience, Inc. Common Stock stock?
Investing in Niagen Bioscience, Inc. Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the NAGE chart and related analysis on metatrader.com as part of your research.